LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
12.30
+0.63 (5.40%)
At close: Mar 9, 2026, 4:00 PM EDT
12.30
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:01 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $384.87 million as of March 9, 2026. Its market cap has decreased by -43.89% in one year.
Market Cap
384.87M
Enterprise Value
183.65M
1-Year Change
-43.89%
Ranking
Category
Stock Price
$12.30
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $384.87M, a decrease of -6.96%. That is a compound annual growth rate of -3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 365.15M | -27.06% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 385.91M |
| Monopar Therapeutics | 384.98M |
| Shattuck Labs | 379.05M |
| Ginkgo Bioworks Holdings | 378.35M |
| Aclaris Therapeutics | 369.02M |
| Candel Therapeutics | 361.84M |
| Bicycle Therapeutics | 360.71M |
| Absci | 357.88M |